
VERAXA Biotech AG Completes Business Combination, Begins Trading on Nasdaq
VERAXA Biotech AG, formed from a business combination with Voyager Acquisition Corp., starts trading on Nasdaq under VRXA, advancing its BiTAC platform for cancer therapies.
Read full story























